Comparing intravitreal bevacizumab, sub threshold macular laser (STML) and intravitreal dexamethasone implant (0.7mg) in the initial treatment of diabetic macular edema (DME) in a resident led clinic

Mughal Mansoor; Chang Eileen; Alexander John Matthew; Morcos Marcelle M.

首页> 外文期刊>Investigative ophthalmology & visual science >Comparing intravitreal bevacizumab, sub threshold macular laser (STML) and intravitreal dexamethasone implant (0.7mg) in the initial treatment of diabetic macular edema (DME) in a resident led clinic

【24h】

Comparing intravitreal bevacizumab, sub threshold macular laser (STML) and intravitreal dexamethasone implant (0.7mg) in the initial treatment of diabetic macular edema (DME) in a resident led clinic

机译：将玻璃体外贝伐单抗，亚阈值黄斑激光（STML）和玻璃体内地塞米松植入物（0.7mg）进行比较在常驻LED诊所的糖尿病黄斑水肿（DME）的初始治疗中

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Investigative ophthalmology & visual science》 |2019年第9期|共2页
作者
Mughal Mansoor; Chang Eileen; Alexander John Matthew; Morcos Marcelle M.;
展开▼
作者单位

Nassau Univ Med Cent Ophthalmol E Meadow NY USA;

Nassau Univ Med Cent Ophthalmol E Meadow NY USA;

Nassau Univ Med Cent Ophthalmol E Meadow NY USA;

Nassau Univ Med Cent Ophthalmol E Meadow NY USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类眼科学;
关键词

相似文献

外文文献
中文文献
专利

1. Comparing intravitreal bevacizumab, sub threshold macular laser (STML) and intravitreal dexamethasone implant (0.7mg) in the initial treatment of diabetic macular edema (DME) in a resident led clinic [J] . Mughal Mansoor, Chang Eileen, Alexander John Matthew, Investigative ophthalmology & visual science . 2019,第9期

机译：将玻璃体外贝伐单抗，亚阈值黄斑激光（STML）和玻璃体内地塞米松植入物（0.7mg）进行比较在常驻LED诊所的糖尿病黄斑水肿（DME）的初始治疗中
2. Comparing intravitreal bevacizumab and sub threshold macular laser (STML) in the initial treatment of diabetic macular edema (DME) in a resident lead clinic. [J] . Mughal Mansoor, Ryan Phan, Chang Eileen, Investigative ophthalmology & visual science . 2018,第9期

机译：比较玻璃体外贝伐单抗和亚阈值黄斑激光（STML）在常驻诊所糖尿病黄斑水肿（DME）的初始治疗中。
3. Comparing intravitreal bevacizumab and sub threshold macular laser (STML) in the initial treatment of diabetic macular edema (DME) in a resident lead clinic. [J] . Mughal Mansoor, Ryan Phan, Chang Eileen, Investigative ophthalmology & visual science . 2018,第9期

机译：比较玻璃体外贝伐单抗和亚阈值黄斑激光（STML）在常驻诊所糖尿病黄斑水肿（DME）的初始治疗中。
4. Pharmacokinetic Modeling to Improve the Design of Intravitreal Corticosteroid Implants for Treating Macular Edema [C] . Susan S. Lee, David Z. DArgenio, Rex A. Moats, Controlled Release Society Annual Meeting and Exposition . 2007

机译：药物动力学模型可改善玻璃体皮质类固醇植入物治疗黄斑水肿的设计
5. Prediction of visual acuity loss and indications for laser treatment in patients with diabetic macular edema using the Heidelberg Retina Tomograph. [D] . O'Neal, Dennis A. 2007

机译：使用海德堡视网膜断层扫描仪预测糖尿病性黄斑水肿患者的视力下降和激光治疗的适应症。
6. Combined Intravitreal Dexamethasone Implant And Micropulse Yellow Laser For Treatment Of Anti-VEGF Resistant Diabetic Macular Edema [O] . Ahmed Hosni Abd Elhamid 2017

机译：玻璃体腔内地塞米松联合微脉冲黄激光治疗抗VEGF糖尿病性黄斑水肿
7. Vision-Related Quality of Life Outcomes in the BEVORDEX Study: A Clinical Trial Comparing Ozurdex Sustained Release Dexamethasone Intravitreal Implant and Bevacizumab Treatment for Diabetic Macular Edema [O] . Christine Aroney, Samantha Fraser-Bell, Ecosse L. Lamoureux, 2016

机译：Bevordex研究中的视觉相关质量结果：临床试验，比较Ozurdex持续释放地塞米松玻璃体植入物和Bevacizumab治疗糖尿病黄斑水肿

Comparing intravitreal bevacizumab, sub threshold macular laser (STML) and intravitreal dexamethasone implant (0.7mg) in the initial treatment of diabetic macular edema (DME) in a resident led clinic

著录项

相似文献

相关主题

期刊订阅